Advertisement

Topics

Reata Pharmaceuticals, Inc. Receives Orphan Drug Designation For Omaveloxolone For The Treatment Of Friedreich???s Ataxia

20:00 EDT 21 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Reata Pharmaceuticals, Inc. Receives Orphan Drug Designation For Omaveloxolone For The Treatment Of Friedreich???s Ataxia

NEXT ARTICLE

More From BioPortfolio on "Reata Pharmaceuticals, Inc. Receives Orphan Drug Designation For Omaveloxolone For The Treatment Of Friedreich???s Ataxia"

Advertisement
Quick Search
Advertisement
Advertisement